Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
Gliclazide (GCZ), an antidiabetic medication, has poor solubility and limited oral bioavailability due to substantial first-pass metabolism. Thus, the purpose of the current study was to optimize and formulate a GCZ nanosuspension (NS) employing the antisolvent precipitation technique. A three-facto...
Main Authors: | , , , |
---|---|
格式: | 文件 |
语言: | English |
出版: |
MDPI AG
2022-09-01
|
丛编: | Pharmaceutics |
主题: | |
在线阅读: | https://www.mdpi.com/1999-4923/14/9/1947 |